Annual Report 2020

FOR THE YEAR ENDED 31 DECEMBER 2020 截至二零二零年十二月三十一日止年度 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 綜合財務報告附註 251 2020 ANNUAL REPORT 年報 36 以股份支付支出之交易 （續） (a) 本公司之購股權計劃 （續） 二零零二計劃 截至二零一九年十二月三十一日止 年度，根據二零零二計劃，亦無授 出之購股權已被行使或註銷，惟有 4,000,000 股購股權失效。於二零 一九年十二月三十一日，沒有未行 使的購股權。 下表披露合資格人士關於二零零二 計劃持有本公司購股權資料及其截 至二零一九年十二月三十一日止年 度之持股變動： 36 SHARE-BASED PAYMENT TRANSACTIONS (continued) (a) The Company’s share option scheme (continued) 2002 Scheme During the year ended 31 December 2019, no share options granted under the 2002 Scheme had been exercised or cancelled while 4,000,000 share options have lapsed. No share options were outstanding as at 31 December 2019. The following table discloses details of the Company’s share options granted under 2002 Scheme held by eligible participants and movements in such holdings in relation thereto during the year ended 31 December 2019: Number of share options for 2019 二零一九年購股權數目 Grantees At 1.1.2019 Lapsed during the year At 31.12.2019 Date of grant Exercise period Exercise Price per share 獲授予購股權人士 於二零一九年 一月一日 年內失效 於二零一九年 十二月三十一日 授出日期 行使期間 每股行使價 (Note a) HK$ （附註 a ） 港幣 Employees other than directors of the Company 1,200,000 (1,200,000) (Note b) （附註 b ） – 13.7.2009 13.7.2009 – 12.7.2019 0.680 僱員（本公司董事除外） 1,200,000 (1,200,000) (Note b) （附註 b ） – 13.7.2009 1.1.2010 – 12.7.2019 0.680 1,600,000 (1,600,000) (Note b) （附註 b ） – 13.7.2009 1.1.2011-12.7.2019 0.680 4,000,000 (4,000,000) – Exercisable at year end – 於年底可行使 Weighted average exercise price 0.680 0.680 – 加權平均行使價